Synthetic Biology Market Growth Analysis and 2018 Worldwide Forecasts

Nov 25, 2014, 03:00 ET from ReportsnReports

DALLAS, November 25, 2014 /PRNewswire/ -- adds Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018 as well as Global Synthetic Biology Market 2014-2018 research reports to the biotechnology intelligence collection of its online library.

The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic genes and chassis to develop synthetic organisms from scratch. The Synthetic Biology Market by Tool, Technology, Application - Global Forecast to 2018 research report says in 2013, the oligo nucleotides segment accounted for the largest share of the global synthetic biology market, by tool, while enabling technologies accounted for the largest share of the synthetic biology market, by technology. The medical application segment accounted for a major share of the synthetic biology applications market in 2013. North America accounted for the largest share of the global synthetic biology market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, Europe is expected to witness the highest growth rate, with emphasis on Germany, U.K., France, Denmark, Switzerland, and Rest of Europe. These countries are expected to serve as revenue pockets for synthetic biology manufacturers.

The global synthetic biology market witnesses high-competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market. This report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment)for strengthening their market shares.

According to this synthetic biology market report, the industry is expected to reach $5,630.4 Million by 2018 from $1,923.1 Million in 2013, growing at a CAGR of 24% during the forecast period. Companies profiled in this research include Amyris Inc., DuPont, Genscript USA Inc., Intrexon Corporation, Integrated DNA Technologies (IDT) Inc., New England Biolabs Inc., Novozymes, Royal DSM N.V., Synthetic Genomics Inc. and Thermo Fisher Scientific Inc. Order a copy of this research at .

The Global Synthetic Biology Market 2014-2018 research report categorizes the industry on the basis of technology into four segments: Genome Engineering, DNA Sequencing, Bioinformatics and Biological Components and Integrated Systems. The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment. This research ( ) forecasts that the Global Synthetic Biology market will grow at a CAGR of 33.8% over the period 2013-2018.

The Global Synthetic Biology Market 2014-2018 report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. It helps answer questions like what will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?

Companies active in the synthetic biology market and discussed in this research include Amyris Inc., E. I. du Pont de Nemours and Co., Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Algenol Biofuels Inc., ATG: biosynthetics GmbH, Bayer AG, Bioneer Corp., Biosearch Technologies Inc., Bristol-Myers Squibb Co., CBC Comprehensive Biomarker Center GmbH, Cobalt Technologies, Evolva Holdings SA, Exxon Mobil Corp., GeneWorks Pty Ltd., Genomatica Inc., Gevo Inc., Ginkgo Bioworks, Green Biologics Ltd., New England Biolabs Inc., OriGene Technologies Inc., REG Life Sciences LLC, Royal DSM and Synthorx Inc. Order a copy of this report at .

Explore other newly published biotechnology market research reports available with at .

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Priyank Tiwari / Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel:  +1-888-391-5441  

Connect With Us on:  

Facebook:  https: //


Twitter:  https: //

G+ / Google Plus:


RSS/Feeds:  http: //

SOURCE ReportsnReports